Hansoh Pharmaceutical Group Company Limited (3692.HK)
HKD 18.5
(0.11%)
HKD 18.5
(0.11%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 9.07 Billion CNY | 6.59% |
| 2022 | 8.51 Billion CNY | -6.1% |
| 2021 | 9.06 Billion CNY | 14.94% |
| 2020 | 7.88 Billion CNY | -0.73% |
| 2019 | 7.94 Billion CNY | 11.6% |
| 2018 | 7.11 Billion CNY | 24.24% |
| 2017 | 5.73 Billion CNY | 13.8% |
| 2016 | 5.03 Billion CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 5.91 Billion CNY | 0.0% |
| 2023 FY | 9.07 Billion CNY | 6.59% |
| 2023 Q2 | 3.98 Billion CNY | 0.0% |
| 2023 Q4 | 5.09 Billion CNY | 0.0% |
| 2022 Q4 | 4.47 Billion CNY | 0.0% |
| 2022 Q2 | 4.03 Billion CNY | 0.0% |
| 2022 FY | 8.51 Billion CNY | -6.1% |
| 2021 FY | 9.06 Billion CNY | 14.94% |
| 2021 Q2 | 3.98 Billion CNY | 0.0% |
| 2021 Q4 | 5.07 Billion CNY | 0.0% |
| 2020 FY | 7.88 Billion CNY | -0.73% |
| 2020 Q4 | 4.27 Billion CNY | 0.0% |
| 2020 Q2 | 3.61 Billion CNY | 0.0% |
| 2019 Q2 | 4.21 Billion CNY | 0.0% |
| 2019 FY | 7.94 Billion CNY | 11.6% |
| 2019 Q4 | 3.72 Billion CNY | 0.0% |
| 2018 FY | 7.11 Billion CNY | 24.24% |
| 2018 Q4 | 3.59 Billion CNY | 0.0% |
| 2018 Q2 | 3.52 Billion CNY | 0.0% |
| 2017 Q4 | 1.77 Billion CNY | 0.0% |
| 2017 Q1 | 1.43 Billion CNY | 0.0% |
| 2017 Q2 | 1.43 Billion CNY | 0.0% |
| 2017 FY | 5.73 Billion CNY | 13.8% |
| 2016 Q4 | 1.43 Billion CNY | 0.0% |
| 2016 Q1 | 1.25 Billion CNY | 0.0% |
| 2016 FY | 5.03 Billion CNY | 0.0% |
| 2016 Q2 | 1.25 Billion CNY | 0.0% |
| 2015 Q4 | 1.25 Billion CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -5318.753% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | -39.069% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -31426.262% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -2198.036% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 25583.647% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -1545.703% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | -489.423% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -1825.121% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -4088.24% |
| SSY Group Limited | 3.48 Billion HKD | -160.031% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -2740.479% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -1362.258% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 79.078% |